Market Tracker

10/23 4:21am ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.5304
Data as of Oct 22
 -0.0047 / -0.88%
Today’s Change
0.40
Today|||52-Week Range
1.10
+14.71%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.54
Today’s open0.54
Day’s range-- - --
Volume393,819
Average volume (3 months)720,731
Market cap$67.4M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+15.15%
Earnings growth (this year)+8.93%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...-0.22-4.19%
ASTMAastrom Biosciences ...+0.04+1.37%
ADHDAlcobra Ltd+0.56+10.94%
CBRXColumbia Laboratorie...-0.06-1.01%
Data as of 10/22/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$21.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
President, Chief Operating Officer &
Secretary
Patrick L. Keran
Corporate headquarters
San Diego, California

Forecasts